Carl Zeiss Meditec AG Product Pipeline Analysis
| Publication Date | August 2008 |
|---|---|
| Publisher | Global Markets Direct |
| Product Type | Report |
| Pages | 47 |
| ISBN Number | not applicable |
| Product Code | GMD04818 |
Summary
This report is an insightful source for data, analysis and strategic insights into a Carl Zeiss Meditec AG's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.
Scope
- Details of development stage by sector and equipment type.
- Pipeline products grouped by therapy area, development stage and trial phase.
- Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
- Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
- Product updates covering estimated approval dates and estimated launch dates.
- Descriptions of novel technologies relating to pipeline products of the company.
- Patents and patent applications covered for the product.
- News updates on key events relating to the product and its development.
Reasons to buy
- A single source to fulfill competitor information relating to products in development.
- Identify pipeline products that are potential competitor to your product lines.
Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
- Access clinical trial information to map trial results and plan targeted marketing activities.
- Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
- Identification of potential investment opportunities.
- Build up knowledge base for potential distribution and marketing partners.
- Helps avoid patent infringement.
- Timelines from concept to market lets you keep track of market potential build for a new product.
Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.
Content
- 1 List of Tables
- 1.2 List of Figures
- 2 Company Snapshot
- 2.1 Key Information
- 2.2 Company Overview
- 2.3 Financial Performance
- 3 Business Description
- 3.1 Business Overview
- 3.2 Neuro/ENT
- 3.2.1 Overview
- 3.2.2 Financials
- 3.2.3 Capital Expenditure
- 3.2.4 Market View
- 3.2.5 Key Strategies
- 3.3 Ophthalmic Systems
- 3.3.1 Overview
- 3.3.2 Financials
- 3.3.3 Market View
- 3.3.4 Key Strategies
- 3.3.5 Capital Expenditure
- 3.4 Ophthalmic Systems
- 3.4.1 Overview
- 3.4.2 Financials
- 3.4.3 Market View
- 3.4.4 Key Strategies
- 3.5 Surgical Ophthalmology
- 3.5.1 Overview
- 3.5.2 Financials
- 3.5.3 Capital Expenditure
- 3.5.4 Market View
- 3.6 Major Products and Services
- 3.6.1 Overview
- 4 Business Strategy
- 4.1 Mission Statement
- 4.2 Strategy
- 4.3 Corporate Social Responsibility
- 4.3.1 Overview
- 5 Value Chain Analysis
- 5.1 Manufacturing
- 5.1.1 In House Manufacturing
- 5.1.2 Outsourcing
- 5.2 Product Development
- 5.2.1 Regulatory Approvals
- 5.2.2 Clinical Trials
- 5.2.3 Research and Development
- 5.3 Sales and Marketing
- 5.3.1 Partnerships and Alliances
- 5.3.2 Licensing Agreements
- 5.1 Manufacturing
- 6 Competitors
- 7 Key Employees
- 8 Key Employee Biographies
- 9 Company Statement
- 10 Locations And Subsidiaries
- 10.1 Head Office
- 10.2 Other Locations & Subsidiaries
- 11 Recent Developments
- 11.1 Strategy And Business Planning
- 11.1.1 Apr 30, 2008: Carl Zeiss Opens Technology Center In India
- 11.1.2 Mar 27, 2008: CZM Opens Advanced Imaging Centre At Singapore
- 11.2 Financial Announcements
- 11.2.1 Aug 14, 2008: CZM Reports First Nine Months 2008 Results
- 11.2.2 May 13, 2008: CZM Reports H1 2007/08 Results
- 11.2.3 Aug 08, 2007: CZM First Nine Months 2007 Results
- 11.2.4 Mar 01, 2007: CZM Reports Fiscal 2005/06 Results
- 11.2.5 Feb 14, 2007: CZM Reports Q1 2006/07 Results
- 11.3 Corporate Communications
- 11.3.1 Jul 21, 2008: CZM Announces Management Board Changes
- 11.3.2 Apr 25, 2008: Carl Zeiss Vision Appoints COO
- 11.3.3 Oct 08, 2007: CZM Appoints New Board Member
- 11.3.4 Aug 23, 2007: CZM Announces Supervisory Board Changes
- 11.3.5 Sep 11, 2006: CZM Appoints Executive Board Member
- 11.4 Legal and Regulatory
- 11.4.1 Nov 13, 2006: CZM Lawsuit with IntraLase
- 11.4.2 Oct 13, 2006: CZM Wins Against Complainants In Court
- 11.5 Product News
- 11.5.1 Jul 17, 2008: Carl Zeiss Meditec Reaches 1,000 Cirrus HD-OCT Placements
- 11.5.2 Apr 04, 2008: Carl Zeiss Meditec Delivers Key Technological Advances In Optical Coherence Tomography
- 11.5.3 Apr 04, 2008: Carl Zeiss To Introduce Stratus OCT At The American Society Of Cataract And Refractive Surgeons
- 11.5.4 Mar 10, 2008: Carl Zeiss Meditec Inc. Introduces New Humphrey Field Analyzer
- 11.5.5 Mar 06, 2008: Carl Zeiss Meditec Introduces First Femtosecond Laser In Asia
- 11.5.6 Nov 13, 2007: Carl Zeiss Meditec Introduces OPMI pico Microscope
- 11.1 Strategy And Business Planning
- 12 Carl Zeiss Meditec AG Pipeline Products
- 12.1 Carl Zeiss Meditec AG Product Pipeline Analysis
- 12.1.1 Carl Zeiss Meditec AG Pipeline Products By Equipment Type
- 12.1.2 Carl Zeiss Meditec AG Pipeline Products By Development Stage
- 12.1.3 Carl Zeiss Meditec AG Pipeline Products By Therapy Area
- 12.1.4 Carl Zeiss Meditec AG Pipeline Products By Clinical Trials
- 12.2 IOL Master
- 12.2.1 Product Description
- 12.2.2 Product Status
- 12.3 VISULAS 690 PLUS
- 12.3.1 Product Description
- 12.3.2 Product Status
- 12.4 Multifocal IOL
- 12.4.1 Product Description
- 12.4.2 Product Status
- 12.5 New laser system
- 12.5.1 Product Description
- 12.5.2 Product Status
- 12.6 VISUCAM platform-New applications
- 12.6.1 Product Description
- 12.6.2 Product Status
- 12.6.3 Clinical Trials
- 12.6.4 Product Patent Details
- 12.1 Carl Zeiss Meditec AG Product Pipeline Analysis
- 13 Appendix
- 13.1 Methodology
- 13.1.1 Coverage
- 13.1.2 Secondary Research
- 13.1.3 Primary Research
- 13.1.4 Expert Panel Validation
- 13.2 Contact Us
- 13.3 About Global Markets Direct
- 13.4 Disclaimer
- 13.1 Methodology
- 1 List of Tables
- Table 1: Carl Zeiss Meditec AG,Key Facts, 2007
- Table 2: Carl Zeiss Meditec AG, Key Employees, 2007
- Table 3: Carl Zeiss Meditec AG, Other Locations
- Table 4: Carl Zeiss Meditec AG, Subsidiaries
- Table 5: Carl Zeiss Meditec AG Pipeline Products by Equipment Type
- Table 6: Carl Zeiss Meditec AG Pipeline Products By Development Stage
- Table 7: Carl Zeiss Meditec AG Pipeline Products By Therapy Area
- Table 8: Carl Zeiss Meditec AG Pipeline Products By Clinical Trials
- 1.2 List of Figures
- Figure 1: Carl Zeiss Meditec AG, Value Chain Analysis
- Figure 2: Carl Zeiss Meditec AG Pipeline Products By Equipment Type
- Figure 3: Carl Zeiss Meditec AG Pipeline Products By Equipment Type
- Figure 4: Carl Zeiss Meditec AG Pipeline Products By Development Stage
- Figure 5: Global Markets Direct Methodology
About this Product
Delivery Details
Product features / use
| Scope | Expert Insight/Opinion | ![]() |
| Profiles | In-depth Company Insight | ![]() |
| Features | Primary Research Data | ![]() |
Related Products
- AstraZeneca’s Crestor Could Revolutionise Heart Disease Treatment >>
- Sanofi-Aventis and Pfizer Stop Development of a Class of Anti-obesity drugs >>
- Pharma Companies turn Webwards to Recruit Patients as 90% of Clinical Trials Face Delay >>
- Have your Healthcare Costs Reduced with Personalized Healthcare >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories
















